Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Cardiovascular disease

Daily aspirin cuts venous thromboembolism recurrence

Aspirin can be used to prevent venous thromboembolism

Source: MaraZe /

Aspirin may represent an inexpensive, safe and convenient alternative to warfarin and other anticoagulant drugs

Unprovoked venous thromboembolism (VTE) carries a high long-term recurrence risk. Nevertheless, most patients discontinue thromboprophylaxis within six months owing to the cost, inconvenience and bleeding risk associated with standard oral anticoagulants.

Now, an analysis of 1,224 patients with a first unprovoked VTE has found that aspirin at a dose of 100mg/day cuts VTE recurrence by up to 42% over two years, without significantly increasing the risk of bleeding.

The INSPIRE study results, published in Circulation (online, 25 August 2014)[1], suggest that aspirin may represent an inexpensive, safe and convenient alternative to warfarin and other anticoagulant drugs, according to John Simes, from the University of Sydney, Australia, and his fellow investigators.

“If cost is the main consideration, aspirin is a particularly useful therapy, because it is cost-saving,” the researchers say.




Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066284

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.